Home › Cutaneous T-Cell Lymphoma › Michigan › Ann Arbor
Cutaneous T-Cell Lymphoma clinical trials in Ann Arbor, MI
3 studies for Cutaneous T-Cell Lymphoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RecruitingPhase 1
- University of Michigan, Ann Arbor
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
RecruitingPhase 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Michigan, Ann Arbor
Cutaneous T-Cell Lymphoma trials in other cities
- New York City, NY9 studies
- Baldwin Park, CA8 studies
- Boston, MA5 studies
- Houston, TX5 studies
- New Haven, CT4 studies
- Chicago, IL3 studies
- Scottsdale, AZ3 studies
- Durham, NC3 studies
- Tampa, FL3 studies
- Columbus, OH3 studies
- Rochester, MN3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.